title: Breakthrough drug category demands more communication.
authors.forename: John
authors.initials: J
authors.lastname: Carroll
mesh_terms: D017326:Clinical Trials, Phase III as Topic; D003142:Communication; D017277:Drug Approval / Q000458:organization & administration*; D055808:Drug Discovery / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D014481:United States; D014486:United States Food and Drug Administration